Several stocks experienced declines in Monday’s trading session, with Larsen & Toubro, Sun Pharma, HCL Tech, Infosys and ITC among the top losers on the Nifty 50. At 10:30 am, Larsen & Toubro was trading at Rs 3,641.10, a 0.98% fall from the previous close. Sun Pharma was trading at Rs 1,634.50, down by 0.42%, HCL Tech at Rs 1,483.60, also down by 0.42%, Infosys at Rs 1,442.50, a 0.36% decrease and ITC at Rs 410.25, declining by 0.29%.
Larsen & Toubro Financial Overview:
Larsen & Toubro’s consolidated revenue for the quarter-ending June 2025 stood at Rs 63,678.92 Crore, compared to Rs 55,119.82 Crore in June 2024. The net profit for the same quarter was Rs 4,325.57 Crore, up from Rs 3,440.11 Crore in the previous year. The Earnings Per Share (EPS) for June 2025 was Rs 26.30, compared to Rs 20.26 in June 2024.
The company’s annual consolidated revenue for the year 2025 reached Rs 255,734.45 Crore, a notable increase from Rs 221,112.91 Crore in 2024. The net profit for the year was Rs 17,687.39 Crore, compared to Rs 15,569.72 Crore in the previous year. The EPS for 2025 was Rs 109.36, up from Rs 93.96 in 2024. The Book Value Per Share (BVPS) decreased to Rs 710.12 in 2025 from Rs 746.01 in 2024. The Return on Equity (ROE) slightly increased to 15.39% in 2025 from 15.12% in 2024. The Debt to Equity ratio remained stable at 1.33 in 2025.
Larsen & Toubro – Income Statement (Consolidated):
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Sales | Rs 255,734 Crore | Rs 221,112 Crore | Rs 183,340 Crore | Rs 156,521 Crore | Rs 135,979 Crore |
| Other Income | Rs 4,124 Crore | Rs 4,158 Crore | Rs 2,929 Crore | Rs 2,267 Crore | Rs 3,429 Crore |
| Total Income | Rs 259,859 Crore | Rs 225,270 Crore | Rs 186,269 Crore | Rs 158,788 Crore | Rs 139,408 Crore |
| Total Expenditure | Rs 232,946 Crore | Rs 201,207 Crore | Rs 165,953 Crore | Rs 141,154 Crore | Rs 126,815 Crore |
| EBIT | Rs 26,913 Crore | Rs 24,062 Crore | Rs 20,316 Crore | Rs 17,633 Crore | Rs 12,593 Crore |
| Interest | Rs 3,334 Crore | Rs 3,545 Crore | Rs 3,207 Crore | Rs 3,125 Crore | Rs 3,913 Crore |
| Tax | Rs 5,891 Crore | Rs 4,947 Crore | Rs 4,484 Crore | Rs 4,216 Crore | Rs 4,010 Crore |
| Net Profit | Rs 17,687 Crore | Rs 15,569 Crore | Rs 12,624 Crore | Rs 10,291 Crore | Rs 4,668 Crore |
The sales of Larsen & Toubro increased from Rs 135,979 Crore in March 2021 to Rs 255,734 Crore in March 2025.
Sun Pharma Financial Overview:
Sun Pharma’s consolidated revenue for the quarter-ending June 2025 was Rs 13,851.40 Crore, compared to Rs 12,652.75 Crore in June 2024. The net profit for the same quarter was Rs 2,302.62 Crore, down from Rs 2,871.25 Crore in the previous year. The Earnings Per Share (EPS) for June 2025 was Rs 9.50, compared to Rs 11.80 in June 2024.
The company’s annual consolidated revenue for the year 2025 reached Rs 52,578.44 Crore, a notable increase from Rs 48,496.85 Crore in 2024. The net profit for the year was Rs 10,980.10 Crore, compared to Rs 9,648.44 Crore in the previous year. The EPS for 2025 was Rs 45.60, up from Rs 39.90 in 2024. The Book Value Per Share (BVPS) increased to Rs 301.00 in 2025 from Rs 265.36 in 2024. The Return on Equity (ROE) remained consistent at 15.13% in 2025. The Debt to Equity ratio remained stable at 0.03 in 2025.
Sun Pharma – Income Statement (Consolidated):
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Sales | Rs 52,578 Crore | Rs 48,496 Crore | Rs 43,885 Crore | Rs 38,654 Crore | Rs 33,498 Crore |
| Other Income | Rs 1,965 Crore | Rs 1,354 Crore | Rs 634 Crore | Rs 921 Crore | Rs 835 Crore |
| Total Income | Rs 54,543 Crore | Rs 49,851 Crore | Rs 44,520 Crore | Rs 39,576 Crore | Rs 34,333 Crore |
| Total Expenditure | Rs 40,559 Crore | Rs 38,524 Crore | Rs 34,939 Crore | Rs 34,967 Crore | Rs 31,392 Crore |
| EBIT | Rs 13,983 Crore | Rs 11,326 Crore | Rs 9,580 Crore | Rs 4,608 Crore | Rs 2,940 Crore |
| Interest | Rs 231 Crore | Rs 238 Crore | Rs 172 Crore | Rs 127 Crore | Rs 141 Crore |
| Tax | Rs 2,772 Crore | Rs 1,439 Crore | Rs 847 Crore | Rs 1,075 Crore | Rs 514 Crore |
| Net Profit | Rs 10,980 Crore | Rs 9,648 Crore | Rs 8,560 Crore | Rs 3,405 Crore | Rs 2,284 Crore |
The sales of Sun Pharma increased from Rs 33,498 Crore in March 2021 to Rs 52,578 Crore in March 2025.
HCL Tech Financial Overview:
Story continues below Advertisement
HCL Tech’s consolidated revenue for the quarter-ending June 2025 stood at Rs 30,349.00 Crore, compared to Rs 28,057.00 Crore in June 2024. The net profit for the same quarter was Rs 3,844.00 Crore, down from Rs 4,259.00 Crore in the previous year. The Earnings Per Share (EPS) for June 2025 was Rs 14.18, compared to Rs 15.70 in June 2024.
The company’s annual consolidated revenue for the year 2025 reached Rs 117,055.00 Crore, a notable increase from Rs 109,913.00 Crore in 2024. The net profit for the year was Rs 17,399.00 Crore, compared to Rs 15,710.00 Crore in the previous year. The EPS for 2025 was Rs 64.16, up from Rs 57.99 in 2024. The Book Value Per Share (BVPS) increased to Rs 256.56 in 2025 from Rs 251.46 in 2024. The Return on Equity (ROE) increased to 24.96% in 2025 from 23.00% in 2024. The Debt to Equity ratio remained stable at 0.03 in 2025.
HCL Tech – Income Statement (Consolidated):
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Sales | Rs 117,055 Crore | Rs 109,913 Crore | Rs 101,456 Crore | Rs 85,651 Crore | Rs 75,379 Crore |
| Other Income | Rs 2,485 Crore | Rs 1,495 Crore | Rs 1,358 Crore | Rs 1,067 Crore | Rs 927 Crore |
| Total Income | Rs 119,540 Crore | Rs 111,408 Crore | Rs 102,814 Crore | Rs 86,718 Crore | Rs 76,306 Crore |
| Total Expenditure | Rs 95,635 Crore | Rs 89,888 Crore | Rs 82,973 Crore | Rs 69,447 Crore | Rs 59,942 Crore |
| EBIT | Rs 23,905 Crore | Rs 21,520 Crore | Rs 19,841 Crore | Rs 17,271 Crore | Rs 16,364 Crore |
| Interest | Rs 644 Crore | Rs 553 Crore | Rs 353 Crore | Rs 319 Crore | Rs 511 Crore |
| Tax | Rs 5,862 Crore | Rs 5,257 Crore | Rs 4,643 Crore | Rs 3,428 Crore | Rs 4,684 Crore |
| Net Profit | Rs 17,399 Crore | Rs 15,710 Crore | Rs 14,845 Crore | Rs 13,524 Crore | Rs 11,169 Crore |
The sales of HCL Tech increased from Rs 75,379 Crore in March 2021 to Rs 117,055 Crore in March 2025.
Infosys Financial Overview:
Infosys’ consolidated revenue for the quarter-ending June 2025 stood at Rs 42,279.00 Crore, compared to Rs 39,315.00 Crore in June 2024. The net profit for the same quarter was Rs 6,924.00 Crore, up from Rs 6,374.00 Crore in the previous year. The Earnings Per Share (EPS) for June 2025 was Rs 16.70, compared to Rs 15.38 in June 2024.
The company’s annual consolidated revenue for the year 2025 reached Rs 162,990.00 Crore, a notable increase from Rs 153,670.00 Crore in 2024. The net profit for the year was Rs 26,750.00 Crore, compared to Rs 26,248.00 Crore in the previous year. The EPS for 2025 was Rs 64.50, up from Rs 63.39 in 2024. The Book Value Per Share (BVPS) increased to Rs 231.11 in 2025 from Rs 212.74 in 2024. The Return on Equity (ROE) decreased to 27.87% in 2025 from 29.77% in 2024. The Debt to Equity ratio remained stable at 0.00 in 2025.
Infosys – Income Statement (Consolidated):
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Sales | Rs 162,990 Crore | Rs 153,670 Crore | Rs 146,767 Crore | Rs 121,641 Crore | Rs 100,472 Crore |
| Other Income | Rs 3,600 Crore | Rs 4,711 Crore | Rs 2,701 Crore | Rs 2,295 Crore | Rs 2,201 Crore |
| Total Income | Rs 166,590 Crore | Rs 158,381 Crore | Rs 149,468 Crore | Rs 123,936 Crore | Rs 102,673 Crore |
| Total Expenditure | Rs 128,566 Crore | Rs 121,923 Crore | Rs 115,862 Crore | Rs 93,626 Crore | Rs 75,850 Crore |
| EBIT | Rs 38,024 Crore | Rs 36,458 Crore | Rs 33,606 Crore | Rs 30,310 Crore | Rs 26,823 Crore |
| Interest | Rs 416 Crore | Rs 470 Crore | Rs 284 Crore | Rs 200 Crore | Rs 195 Crore |
| Tax | Rs 10,858 Crore | Rs 9,740 Crore | Rs 9,214 Crore | Rs 7,964 Crore | Rs 7,205 Crore |
| Net Profit | Rs 26,750 Crore | Rs 26,248 Crore | Rs 24,108 Crore | Rs 22,146 Crore | Rs 19,423 Crore |
The sales of Infosys increased from Rs 100,472 Crore in March 2021 to Rs 162,990 Crore in March 2025.
ITC Financial Overview:
ITC’s consolidated revenue for the quarter-ending June 2025 stood at Rs 21,494.79 Crore, compared to Rs 18,457.33 Crore in June 2024. The net profit for the same quarter was Rs 5,274.65 Crore, up from Rs 5,169.37 Crore in the previous year. The Earnings Per Share (EPS) for June 2025 was Rs 4.19, compared to Rs 4.08 in June 2024.
The company’s annual consolidated revenue for the year 2025 reached Rs 75,323.34 Crore, a notable increase from Rs 70,881.00 Crore in 2024. The net profit for the year was Rs 19,926.05 Crore, compared to Rs 20,723.75 Crore in the previous year. The EPS for 2025 was Rs 27.79, up from Rs 16.42 in 2024. The Book Value Per Share (BVPS) decreased to Rs 55.96 in 2025 from Rs 59.99 in 2024. The Return on Equity (ROE) increased to 49.61% in 2025. The Debt to Equity ratio remained stable at 0.00 in 2025.
ITC – Income Statement (Consolidated):
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Sales | Rs 75,323 Crore | Rs 70,881 Crore | Rs 70,936 Crore | Rs 60,668 Crore | Rs 49,272 Crore |
| Other Income | Rs 2,529 Crore | Rs 2,727 Crore | Rs 1,980 Crore | Rs 1,836 Crore | Rs 2,632 Crore |
| Total Income | Rs 77,853 Crore | Rs 73,608 Crore | Rs 72,917 Crore | Rs 62,504 Crore | Rs 51,905 Crore |
| Total Expenditure | Rs 50,991 Crore | Rs 46,450 Crore | Rs 47,008 Crore | Rs 41,742 Crore | Rs 33,915 Crore |
| EBIT | Rs 26,861 Crore | Rs 27,158 Crore | Rs 25,909 Crore | Rs 20,762 Crore | Rs 17,989 Crore |
| Interest | Rs 45 Crore | Rs 45 Crore | Rs 43 Crore | Rs 39 Crore | Rs 44 Crore |
| Tax | Rs 6,890 Crore | Rs 6,388 Crore | Rs 6,438 Crore | Rs 5,237 Crore | Rs 4,555 Crore |
| Net Profit | Rs 19,926 Crore | Rs 20,723 Crore | Rs 19,427 Crore | Rs 15,485 Crore | Rs 13,389 Crore |
The sales of ITC increased from Rs 49,272 Crore in March 2021 to Rs 75,323 Crore in March 2025.
Larsen & Toubro has announced a press release on August 13, 2025, regarding L&T Energy GreenTech partnering with Japan’s ITOCHU for a Green Ammonia Project. The company also announced the schedule of Analyst / Institutional Investors’ Meet. The company announced a final dividend of Rs 34 on May 8, 2025, with the effective date being June 3, 2025. The company had bonus issues with ratio 1:2 on May 29, 2017 and May 22, 2013.
Sun Pharma announced the schedule of Analyst/Institutional Investor Meeting. The company announced a final dividend of Rs 5.50 per share on May 22, 2025, with the effective date being July 7, 2025. The company had a bonus issue with ratio 1:1 on May 28, 2013. The company had splits with new face value of Rs 1 on September 24, 2010.
HCL Tech has received recognition in six Gartner Voice of the Customer Reports across IT Services Markets. The company announced an interim dividend of Rs 12 per share on July 14, 2025, with the effective date being July 18, 2025. The company had a bonus issue with ratio 1:1 on October 23, 2019.
Infosys joint venture agreement with Telstra Limited. The company announced a final dividend of Rs 22 per share on April 17, 2025, with the effective date being May 30, 2025. The company had a bonus issue with ratio 1:1 on July 13, 2018.
ITC has announced scheme of amalgamation of Sresta Natural Bioproducts Private Limited and Wimco Limited with ITC Limited. The company announced a final dividend of Rs 7.85 per share on May 22, 2025, with the effective date being May 28, 2025. The company had a bonus issue with ratio 1:2 on May 20, 2016. The company had splits with new face value of Rs 1 on June 17, 2005.
Moneycontrol analysis indicates a very bullish sentiment for the stock as of August 18, 2025.